Simultaneous methylation profiling of tumor suppressor genes in head and neck cancer

DNA and Cell Biology

Volumn 30, Issue 1, 2011, Pages 17-24

  Yalniz, Zubeyde ^a   Demokan, Semra ^a   Suoglu, Yusufhan ^b   Ulusan, Murat ^b   Dalay, Nejat ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN CHFR; PROTEIN DAPK 1; PROTEIN RAR BETA; PROTEIN RASFF 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DNA MODIFICATION; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DNA METHYLATION; EARLY DETECTION OF CANCER; FEMALE; GENES, TUMOR SUPPRESSOR; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; YOUNG ADULT;

EID: 78651463649     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2010.1090     Document Type: Article

References (60)

1. Banno, K., Yanokura, M., Kawaguchi, M., Kuwabara, Y., Akiyoshi, J., Kobayashi, Y., Iwata, T., Hirasawa, A., Fujii, T., Susumu, N., Tsukazaki, K., and Aoki, D. (2007). Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes. Int J Oncol 31, 41-48.
2. Baumann, S., Keller, G., Puhringer, F., Napieralski, R., Feith, M., H öfler, H., Stein, H.J., and Sarbia, M. (2006). The prognostic impact of O6-methylguanine-DNA methylatransferase (MGMT) promoter hypermethylation in oesophageal adenocarcinoma. Int J Cancer 119, 264-268.
3. Baylin, S.B., Herman, J.G., Graff, J.R., Vertino, P.M., and Issa, J.P. (1998). Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72, 141-196.
4. Bennett, K.L., Karpenko, M., Lin, M., Claus, R., Arab, K., Dyckhoff, G., Plinkert, P., Herpel, E., Smiraglia, D., and Plass, C. (2008). Frequently methylated tumor suppressor genes in head and neck squamous cel carcinoma. Cancer Res 68, 4494-4499.
5. Bock, C., Walter, J., Paulsen, M., and Lengauer, T. (2008). Inter-individual variation of DNA methylation and its implications for large-scale epigenome mapping. Nucleic Acids Res 36, e55.
6. Braggio, E., Maiolino, A., Gouveia, M.E., Magalhães, R., Souto Filho, J.T., Garnica, M., Nucci, M., and Renault, I.Z. (2010). Methylation status of nine tumor suppressor genes in multiple myeloma. Int J Hematol 91, 87-96.
7. Brock, M., Gou, M., Akiyama Muller, A., Wu, T.T., Montgomery, E., Deasel, M., Germonpre, P., Rubinson, L., Heitmiller, R.F., Yang, S.C., Forastiere, A.A., Baylin, S.B., and Herman, J.G. (2003). Prognostic importance of promoter hypermethylation of multiple genes in oeosopharyngeal adenocarcinoma. Clin Cancer Res 9, 2912-2919.
8. Buyru, N., Altinisik, J., Ozdemir, F., Demokan, S., and Dalay, N. (2009). Methylation profiles in breast cancer. Cancer Invest 27, 307-312.
9. Calmon, M.F., Colombo, J., Carvalho, F., Souzo, F.P., Filho, J.F.G., Fukuyama, E.E., Camarga, A.A., Caballero, O.L.S., Tajara, E.H., Cordello, J.A., and Rehal, P. (2007). Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM 23 in head and neck cancer. Cancer Genet Cytogenet 173, 31-37.
10. tra, W.H., Sidransky, D., and Califano, J.A. (2008). Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma. Clin Cancer Res 14, 97-107.
11. Dammann, R., Schagdarsurengin, U., Seidel, C., Strunnikova, M., Rastetter, M., Baier, K., and Pfeifer, G.P. (2005). The tumor suppressor RASSF1A in human carcinogenesis: an update. Histol Histopathol 20, 645-663. (Pubitemid 40468282)
12. De Fraipont, F., Moro-Sibilot, D., Michelland, S.,Brambilla, E., Brambilla, C., and Favrot, M.C. (2005). Promoter methylation of genes in bronchial lavages: a marker for early diagnosis of primary and relapsing non-small cell lung cancer. Lung Cancer 50, 199-209.
13. Demokan, S., Suoglu, Y., Demir, D., Gozeler, M., and Dalay, N. (2006). Microsatellite instability and methylation of DNA mismatch repair genes in head and neck cancer. Ann Oncol 17, 995-999.
14. Dikshit, R.P., Gillio-Tos, A., Brennan, P., De Marco, L., Fiano, V., Martinez-Penuela, J.M., Boffetta, P., and Merletti, F. (2007). Hypermethylation, risk factors, clinical characteristics and survival in 235 patients with laryngeal and hypopharyngeal cancers. Cancer 110, 1745-1750.
15. Esteller, M. (2007). Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 16, R50-R59. (Pubitemid 47241842)
16. Esteller, M., Corn, P.G., Baylin, S.B., and Herman, J.G. (2001). A gene hypermethylation profile of human cancer. Cancer Res 61, 3225-3229.
17. Fackler, M.J., McVeigh, M., Mehrotra, J., Blum, M.A., Lange, J., Lapides, A., Garrett, E., Argani, P., and Sukumar, S. (2004). Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer. Cancer Res 64, 4442-4452. (Pubitemid 38856915)
18. Fan, C.Y. (2004). Epigenetic alterations in head and neck cancer: prevalence, clinical significance and implications. Curr Oncol Rep 6, 152-161.
19. Feinberg, A.P. (2004). The epigenetics of cancer etiology. Semin Cancer Biol 14, 427-432.
20. Galm, O., Wilop, S., Lü ders, C., Jost, E., Gehbauer, G., Herman, J.G., and Osieka, R. (2005). Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia. Ann Hematol 84 Suppl 1, 39-46.
21. Galm, O., Wilop, S., Reichelt, J., Jost, E., Gehbauer, G., Herman, J.G., and Osieka, R. (2004). DNA methylation changes in multiple myeloma. Leukemia 18, 1687-1692.
22. Gao, Y., Lou, G., Zhang, G.M., Sun, X.W., Ma, Y.Y., Yang, Y.M., and Liu, G. (2009). CHFR promoter hypermethylation and reduced CHFR mRNA expression in ovarian cancer. Int J Biol Markers 24, 83-89.
23. Gao, Y.J., Xin, Y., Zhang, J.J., and Zhou, J. (2008). Mechanism and pathobiologic implications of CHFR promoter methyla-tion in gastric carcinoma. World J Gastroenterol 14, 5000-5007.
24. Hasegawa, M., Nelson, H.H., Peters, E., Ringstrom, E., Posner, M., and Kelsey, K.T. (2002). Patterns of gene promoter hy-permethylation in squamous cell cancer of the head and neck. Oncogene 21, 4231-4236.
25. Henken, F.E., Wilting, S.M., Overmeer, R.M., van Rietschoten, J.G., Nygren, A.O., Errami, A., Schouten, J.P., Meijer, C.J., Snijders, P.J., and Steenbergen, R.D. (2007). Sequential gene promoter methylation during HPV-induced cervical carcino-genesis. Br J Cancer 97, 1457-1464.
26. Jo, H., Kang, S., Kim, J.W., Kang, G.H., Park, N.H., Song, Y.S., Park, S.Y., Kang, S.B., and Lee, H.P. (2007). Hypermethylation of the COX-2 gene is a potential prognostic marker for cervical cancer. J Obstet Gynecol Oncol 33, 236-241.
27. Jones, P.A., and Baylin, S.B. (2002). The fundamental role of epigenetic events in cancer. Nature Rev Genet 3, 415-428.
28. Jones, P.A., and Baylin, S.B. (2007). The epigenomics of cancer. Cell 128, 683-692.
29. Kim, H., Kwon, Y.M., Kim, J.S., Lee, H., Park, J.H., Shim, Y.M., Han, J., Park, J., and Kim, D.H. (2004). Tumor specific meth-ylation in bronchial lavage for the early detection of non-small cell lung cancer. J Clin Oncol 22, 2363-2370.
30. Kim, J.C., Choi, J.S., Roh, S.A., Cho, D.H., Kim, T.W., and Kim, Y.S. (2010). Promoter methylation of specific genes is associated with the phenotype and progression of colorectal ade-nocarcinomas. 17, 1767-1776.
31. Kissil, J.L., Feinstein, E., Cohen, O., Jones, P.A., Tsai, Y.C., Knowles, M.A., Eydman, M.E., and Kimichi, A. (1997). DAP-kinase loss of expression in various carcinoma and B-cell lymphoma cell lines: posible implications for role as tumor suppressor gene. Oncogene 15, 403-407.
32. Kuang, S.Q., Bai, H., Fang, Z.H., Lopez, G., Yang, H., Tong, W., Wang, Z.Z., and Garcia-Manero, G. (2010). Aberrant DNA methylation and epigenetic inactivation of Eph receptor ty-rosine kinases and ephrin ligands in acute lymphoblastic leukemia. Blood 115, 2412-2419.
33. Laird, P.W. (2003). The power and promise of DNA methylation markers. Nat Rev Cancer 3, 253-266.
34. Lemaire, F., Millon, R., Young, J., Cromer, A., Wasylyk, C., Schultz, I., Muller, D., Marchal, P., Zhao, C., Melle, D., Bracco, L., Abecassis, J., and Wasylyk, B. (2003). Differential expression profiling of head and neck squamous cell carcinoma (HNSCC). Br J Cancer 89, 1940-1949.
35. Marsit, C.J., Christensen, B.C., Houseman, E.A., Karagas, M.R., Wrensch, M.R., Yeh, R.F., Nelson, H.H., Wiemels, J.L., Zheng, S., Posner, M.R., McClean, M.D., Wiencke, J.K., and Kelsey, K.T. (2009). Epigenetic profiling reveals etiolocigally distinct patterns of DNA methylation in head and neck squamous cell carcinoma. Carcinogenesis 30, 416-422.
36. Nayak, C.S., Carvalho, A.L., Jeronimo, C., Henrique, R., Kim, M.M., Hoque, M.O., Chang, S., Jiang, W.W., Koch, W., Westra, W., Sidransky, D., and Califano, J. (2007). Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma. Laryngoscope 117, 1376-1380.
37. Nygren, A.O.H., Ameziane, N., Duarte, H.M.B., Vijzelaar, R.N.C.P., Waisfisz, Q., Hess, C.J., Schouten, J.P., and Errami, A. (2005). Methlation-specific MLPA (Ms-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res 33, e128.
38. Ogi, K., Toyota, M., Ohe-Toyota, M., Tanaka, N., Naguchi, M., Sonada, T., Kahama, G., and Tokino, T. (2002). Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma. Clin Cancer Res 8, 3164-3171.
39. Oki, E., Zhao, Y., Yoshida, R., Masuda, T., Ando, K., Sugiyama, M., Tokunaga, E., Morita, M., Kakeji, Y., and Maehara, Y. (2009). Checkpoint forkhead-associated and ring-finger promoter hypermethylation correlates with microsatellite instability in gastric cancer. World J Gastroenterol 15, 2520-2525.
40. Puri, S.K., Si, L., Fan, C.Y., and Hanna, E. (2005). Aberrant promoter hypermethylation of multiple genes in head and neck squamous cell carcinoma. Am J Otolaryngol 26, 12-17.
41. Raveh, T., and Kimchi, A. (2001). DAP kinase-a proapoptotic gene that functions as a tumor supressor. Exp Cell Res 264, 185-192.
42. Rosas, S.L., Koch, W., da Costa Carvalho, M.G., Wu, L., Califa-no, J., Westra, W., Jen, J., and Sidransky, D. (2001). Promoter hypermethylation patterns of p16, O6-methylguanine DNA methyltransferase and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 161, 939-942.
43. Sanchez-Caspedes, M., Esteller, M., Wu, L., Newroz-Danish, H., Yoo, G.H., Koch, W.M., Jen, J., Herman, J.G., and Sidransky, D. (2000). Gene promoter methylation in tumors and serum of head and neck cancer patients. Cancer Res 60, 892-895.
44. Seidl, S., Ackermann, J., Kaufmann, H., Keck, A., Nösslinger, T., Zielinski, C.C., Drach, J., and Zöchbauer-Mü ller, S. (2004). DNA-methylation analysis identifies the E-cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies. Cancer 100, 2598-2606.
45. Shaw, R. (2006). The epigenetics of oral cancer. Int J Oral Max-illofac Surg 35, 101-108.
46. Shaw, R.J., Akufo-Tetteh, E.K., Risk, J.M., Field, J.K., and Li-loglou, T. (2006). Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyr-osequencing. Nucleic Acids Res 34, e78.
47. Shaw, R.J., Hall, G.L., Lowe, D., Liloglou, T., Field, J.K., Sloan, P., and Risk, J.M. (2008). The role of pyrosequencing in head and neck cancer epigenetics: correlation of quantitative methyla-tion data with gene expression. Acta Otolaryngol Head Neck Surg 134, 251-256.
48. Steinmann, K., Sandner, A., Schagdarsurengin, U., and Dam-mann, R.H. (2009). Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma. Oncol Rep 22, 1519-1526.
49. St. John, M.A., Abemayor, E., and Wong, D.T. (2006). Recent new approaches to the treatment of head and neck cancer. Anticancer Drugs 17, 365-375.
50. Tang, X., Khuri, F.R., Lee, J.J., Kemp, B.L., Liu, D., Hong, W.X., and Mao, L. (2000). Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small cell lung cancer. J Natl Cancer Inst 92, 1511-1516.
51. Taniguchi, T., Tischkowitz, M., Ameziane, N., Hodgson, S.V., Matthew, C.G., Joenje, H., Mok, S.C., and D'Andrea, A.D. (2003). Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nature Med 9, 568-574.
52. Terada, K., Okochi-Takada, E., Akashi-Tanaka, S., Miyamoto, K., Taniyama, K., Tsuda, H., Asada, K., Kiminishi, M., and Ush-ijima, T. (2009). Association between CpG island methylation and HER2 amplification in human breast cancers. Carcino-genesis 30, 466-471.
53. Tsou, J.A., Hagen, J.A., Carpenter, C.I., and Laird-Offringa, I.A. (2002). DNA methylation analysis: a powerful new tool for lung cancer diagnosis. Oncogene 21, 5450-5461.
54. Volate, S.R., Muga, S.J., Issa, A.Y., Nitcheva, D., Smith, T., and Wargovich, W.J. (2009). Epigenetic modulation of the retinoid X receptor alpha by green tea in the azoxymethane-Apc Min/p mouse model of intestinal cancer. Mol Carcinog 48, 920-933.
55. Widschwendter, M., and Jones, P.A. (2002). DNA methylation and breast carcinogenesis. Oncogene 21, 5462-5482.
56. Yamashita, M., Toyota, M., Suzuki, H., Nojima, M., Yamamoto, E., Kamimae, S., Watanabe, Y., Kai, M., Akashi, H., Mar-uyama, R., Sasaki, Y., Yamano, H., Sugai, T., Shinomura, Y., Imai, K., Tokino, T., and Itoh, F. (2010). DNA methylation of interferon regulatory factors in gastric cancer and noncancer-ous gastric mucosae. Cancer Sci 101, 1708-1716.
57. Yang, B., Guo, M., Herman, J., and Clark, D.P. (2003). Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 163, 1101-1107.
58. Yanokura, M., Banno, K., Kawaguchi, M., Hirao, N., Hirasawa, A., Susumu, N., Tsukazaki, K., and Aoki, D. (2007). Relationship of aberrant DNA hypermethylation of CHFR with sensitivity to taxanes in endometrial cancer. Oncol Rep 17, 41-48.
59. Zhu, W., Qin, W., Hewett, J.E., and Sauter, E.R. (2010). Quantitative evaluation of DNA hypermethylation in malignant and benign breast tissue and fluids. Int J Cancer 126, 474-482.
60. Zuo, C., Ai, L., Ratliff, P., Suen, J.Y., Hanna, E., Brent, T.P., and Fan, C.Y. (2004). O6-methylguanine DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 13, 967-975.